{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:55:44Z","timestamp":1781636144487,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005690","name":"Universit\u00e4t des Saarlandes","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005690","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Public speaking anxiety (PSA) is present in most individuals with social anxiety disorder (SAD). As for SAD, exposure therapy is considered the gold-standard treatment for PSA. However, it is known that not all patients benefit from it. Recent research (Hauck Behav Res Ther: 104553, 2024) suggests that glucose facilitates fear extinction and consolidation, processes crucial for psychotherapeutic success, demonstrating its potential as an adjuvant to improve the efficacy of exposure therapy. The present study aims to translate previous findings into a clinical context, by studying the effects of glucose on fear exposure for participants with PSA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants with PSA will complete a spaced multi-day public speaking exposure procedure (Cheng J Behav Ther Exp Psychiatry: 54;101-107, 2017), an established and successful method of investigating treatment for PSA (Culver J Behav Ther Exp Psychiatry: 43:787-93, 2012; Niles Behav Res Ther: 68:27-36, 2015). The effectiveness of the exposure treatment will be measured through self-report assessment and the physiological measures skin conductance (SC), and heart rate (HR). Participants will be randomly assigned to receive either glucose or a placebo prior to exposure in a randomized controlled trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study is the first to investigate glucose administration as cognitive enhancer in a subclinical population, emphasizing the transition from bench to bedside. We provide a detailed study protocol to increase transparency in open science as well as enabling researchers to use the detailed protocol to implement with other manipulations, to improve exposure therapy in the long run.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40359-026-04125-0","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:58:08Z","timestamp":1771423088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sweetening fear exposure: study protocol for a multi-day, randomized controlled trial to study effects of glucose in exposure sessions of participants with public speaking anxiety"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9292-5942","authenticated-orcid":false,"given":"Monika","family":"Lehnert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2409-3817","authenticated-orcid":false,"given":"Tanja","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0286-7852","authenticated-orcid":false,"given":"Lea","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9712-3469","authenticated-orcid":false,"given":"Alexander","family":"Hauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6557-5743","authenticated-orcid":false,"given":"Diana S.","family":"Ferreira de S\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"4125_CR1","unstructured":"2021 Global Burden of Disease (GBD). Institute for Health Metrics and Evaluation.\u00a0https:\/\/vizhub.healthdata.org\/gbd-results\/. 2024."},{"key":"4125_CR2","doi-asserted-by":"publisher","unstructured":"Cao, H., Wu, Y., Yin, H., Sun, Y., Yuan, H., & Tao, M. Global Trends in the Incidence of Anxiety Disorders From 1990 to 2019: Joinpoint and Age-Period-Cohort Analysis Study. JMIR Public Health and Surveillance. 2024;10.\u00a0https:\/\/doi.org\/10.2196\/49609.","DOI":"10.2196\/49609"},{"issue":"3","key":"4125_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.psc.2009.05.001","volume":"32","author":"JJ Arch","year":"2009","unstructured":"Arch JJ, Craske MG. First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives. Psychiatr Clin North Am. 2009;32(3):525\u201347. https:\/\/doi.org\/10.1016\/j.psc.2009.05.001.","journal-title":"Psychiatr Clin North Am"},{"issue":"7","key":"4125_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci9070164","volume":"9","author":"JK Carpenter","year":"2019","unstructured":"Carpenter JK, Pinaire M, Hofmann SG. From extinction learning to anxiety treatment: mind the gap. Brain Sci. 2019;9(7):164. https:\/\/doi.org\/10.3390\/brainsci9070164.","journal-title":"Brain Sci"},{"key":"4125_CR5","unstructured":"Parker, Z. J., Waller, G., Duhne, P. G. S., & Dawson, J. (2018).The role of exposure in treatment of anxiety disorders: A meta-analysis. International Journal of Psychology &Psychological Therapy, 18(1), 111\u2013141."},{"key":"4125_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cpr.2015.08.004","volume":"42","author":"AG Loerinc","year":"2015","unstructured":"Loerinc AG, Meuret AE, Twohig MP, Rosenfield D, Bluett EJ, Craske MG. Response rates for CBT for anxiety disorders: need for standardized criteria. Clin Psychol Rev. 2015;42:72\u201382. https:\/\/doi.org\/10.1016\/j.cpr.2015.08.004.","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"4125_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/wps.20388","volume":"16","author":"AF Jorm","year":"2017","unstructured":"Jorm AF, Patten SB, Brugha TS, Mojtabai R. Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries. World Psychiatry. 2017;16(1):90\u20139. https:\/\/doi.org\/10.1002\/wps.20388.","journal-title":"World Psychiatry"},{"issue":"3","key":"4125_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.janxdis.2008.11.007","volume":"23","author":"AW Bl\u00f6te","year":"2009","unstructured":"Bl\u00f6te AW, Kint MJW, Miers AC, Westenberg PM. The relation between public speaking anxiety and social anxiety: a review. J Anxiety Disord. 2009;23(3):305\u201313. https:\/\/doi.org\/10.1016\/j.janxdis.2008.11.007.","journal-title":"J Anxiety Disord"},{"issue":"1","key":"4125_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/yco.0b013e32834e06dc","volume":"25","author":"CB Pull","year":"2012","unstructured":"Pull CB. Current status of knowledge on public-speaking anxiety. Curr Opin Psychiatry. 2012;25(1):32\u20138. https:\/\/doi.org\/10.1097\/yco.0b013e32834e06dc.","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"4125_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jvoice.2008.09.007","volume":"24","author":"AB Hancock","year":"2010","unstructured":"Hancock AB, Stone MD, Brundage SB, Zeigler MT. Public Speaking Attitudes: Does Curriculum Make a Difference? J Voice. 2010;24(3):302\u20137. https:\/\/doi.org\/10.1016\/j.jvoice.2008.09.007.","journal-title":"J Voice"},{"key":"4125_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jbtep.2016.07.006","volume":"54","author":"J Cheng","year":"2017","unstructured":"Cheng J, Niles AN, Craske MG. Exposure reduces negative bias in self-rated performance in public speaking fearful participants. J Behav Ther Exp Psychiatry. 2017;54:101\u20137. https:\/\/doi.org\/10.1016\/j.jbtep.2016.07.006.","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"1","key":"4125_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jpsychires.2010.05.002","volume":"45","author":"S Knappe","year":"2011","unstructured":"Knappe S, Beesdo-Baum K, Fehm L, Stein MB, Lieb R, Wittchen H-U. Social fear and social phobia types among community youth: differential clinical features and vulnerability factors. J Psychiatr Res. 2011;45(1):111\u201320. https:\/\/doi.org\/10.1016\/j.jpsychires.2010.05.002.","journal-title":"J Psychiatr Res"},{"issue":"4","key":"4125_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/da.22353","volume":"32","author":"P Duits","year":"2015","unstructured":"Duits P, Cath DC, Lissek S, Hox JJ, Hamm AO, Engelhard IM, et al. Updated meta-analysis of classical fear conditioning in the anxiety disorders. Depress Anxiety. 2015;32(4):239\u201353. https:\/\/doi.org\/10.1002\/da.22353.","journal-title":"Depress Anxiety"},{"key":"4125_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijpsycho.2017.09.001","volume":"121","author":"E Forcadell","year":"2017","unstructured":"Forcadell E, Torrents-Rodas D, Vervliet B, Leiva D, Tortella-Feliu M, Fullana MA. Does fear extinction in the laboratory predict outcomes of exposure therapy? A treatment analog study. Int J Psychophysiol. 2017;121:63\u201371. https:\/\/doi.org\/10.1016\/j.ijpsycho.2017.09.001.","journal-title":"Int J Psychophysiol"},{"issue":"11","key":"4125_CR15","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.brat.2004.10.007","volume":"43","author":"S Lissek","year":"2005","unstructured":"Lissek S, Powers AS, McClure EB, Phelps EA, Woldehawariat G, Grillon C, et al. Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav Res Ther. 2005;43(11):1391\u2013424. https:\/\/doi.org\/10.1016\/j.brat.2004.10.007.","journal-title":"Behav Res Ther"},{"issue":"2","key":"4125_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.janxdis.2009.10.011","volume":"24","author":"D Bentz","year":"2010","unstructured":"Bentz D, Michael T, De Quervain DJ-F, Wilhelm FH. Enhancing exposure therapy for anxiety disorders with glucocorticoids: from basic mechanisms of emotional learning to clinical applications. J Anxiety Disord. 2010;24(2):223\u201330. https:\/\/doi.org\/10.1016\/j.janxdis.2009.10.011.","journal-title":"J Anxiety Disord"},{"issue":"1","key":"4125_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0455-0","volume":"9","author":"AH Brueckner","year":"2019","unstructured":"Brueckner AH, Lass-Hennemann J, Wilhelm FH, Ferreira De S\u00e1 DS, Michael T. Cortisol administration after extinction in a fear-conditioning paradigm with traumatic film clips prevents return of fear. Transl Psychiatry. 2019;9(1):128. https:\/\/doi.org\/10.1038\/s41398-019-0455-0.","journal-title":"Transl Psychiatry"},{"key":"4125_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2021.105607","volume":"136","author":"B Hagedorn","year":"2022","unstructured":"Hagedorn B, Wolf OT, Merz CJ. Cortisol before extinction generalization alters its neural correlates during retrieval. Psychoneuroendocrinology. 2022;136:105607. https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105607.","journal-title":"Psychoneuroendocrinology"},{"key":"4125_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.brat.2014.06.009","volume":"60","author":"J Lass-Hennemann","year":"2014","unstructured":"Lass-Hennemann J, Michael T. Endogenous cortisol levels influence exposure therapy in spider phobia. Behav Res Ther. 2014;60:39\u201345. https:\/\/doi.org\/10.1016\/j.brat.2014.06.009.","journal-title":"Behav Res Ther"},{"issue":"2","key":"4125_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/npp.2017.227","volume":"43","author":"CJ Merz","year":"2018","unstructured":"Merz CJ, Hamacher-Dang TC, Stark R, Wolf OT, Hermann A. Neural underpinnings of cortisol effects on fear extinction. Neuropsychopharmacology. 2018;43(2):384\u201392. https:\/\/doi.org\/10.1038\/npp.2017.227.","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"4125_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41386-019-0593-3","volume":"45","author":"DS de Ferreira S\u00e1","year":"2020","unstructured":"Ferreira de S\u00e1 DS, R\u00f6mer S, Br\u00fcckner AH, Issler T, Hauck A, Michael T. Effects of intranasal insulin as an enhancer of fear extinction: a randomized, double-blind, placebo-controlled experimental study. Neuropsychopharmacology. 2020;45(5):753\u201360. https:\/\/doi.org\/10.1038\/s41386-019-0593-3.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"4125_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.31887\/DCNS.2011.13.4\/mdavis","volume":"13","author":"M Davis","year":"2011","unstructured":"Davis M. NMDA receptors and fear extinction: implications for cognitive behavioral therapy. Dialogues Clin Neurosci. 2011;13(4):463\u201374. https:\/\/doi.org\/10.31887\/DCNS.2011.13.4\/mdavis.","journal-title":"Dialogues Clin Neurosci"},{"issue":"3","key":"4125_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41386-019-0552-z","volume":"45","author":"C Ebrahimi","year":"2020","unstructured":"Ebrahimi C, Gechter J, Lueken U, Schlagenhauf F, Wittchen H-U, Hamm AO, et al. Augmenting extinction learning with d-cycloserine reduces return of fear: A randomized, placebo-controlled fMRI study. Neuropsychopharmacology. 2020;45(3):499\u2013506. https:\/\/doi.org\/10.1038\/s41386-019-0552-z.","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"4125_CR24","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/s41386-021-01222-z","volume":"47","author":"SS Inslicht","year":"2022","unstructured":"Inslicht SS, Niles AN, Metzler TJ, Lipshitz SL, Otte C, Milad MR, et al. Randomized controlled experimental study of hydrocortisone and D-cycloserine effects on fear extinction in PTSD. Neuropsychopharmacology. 2022;47(11):1945\u201352. https:\/\/doi.org\/10.1038\/s41386-021-01222-z.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"4125_CR25","doi-asserted-by":"publisher","first-page":"764S","DOI":"10.1093\/ajcn\/67.4.764S","volume":"67","author":"D Korol","year":"1998","unstructured":"Korol D, Gold P. Glucose, memory, and aging. Am J Clin Nutr. 1998;67(4):764S-771S. https:\/\/doi.org\/10.1093\/ajcn\/67.4.764S.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"4125_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0031-9384(99)00040-2","volume":"67","author":"PY Martin","year":"1999","unstructured":"Martin PY, Benton D. The influence of a glucose drink on a demanding working memory task. Physiol Behav. 1999;67(1):69\u201374. https:\/\/doi.org\/10.1016\/S0031-9384(99)00040-2.","journal-title":"Physiol Behav"},{"issue":"1\u20133","key":"4125_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejphar.2004.02.043","volume":"490","author":"C Messier","year":"2004","unstructured":"Messier C. Glucose improvement of memory: a review. Eur J Pharmacol. 2004;490(1\u20133):33\u201357. https:\/\/doi.org\/10.1016\/j.ejphar.2004.02.043.","journal-title":"Eur J Pharmacol"},{"key":"4125_CR28","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.neuropharm.2012.06.030","volume":"64","author":"A Scholey","year":"2013","unstructured":"Scholey A, Macpherson H, S\u00fcnram-Lea S, Elliott J, Stough C, Kennedy D. Glucose enhancement of recognition memory: differential effects on effortful processing but not aspects of \u2018remember-know\u2019 responses. Neuropharmacology. 2013;64:544\u20139. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.06.030.","journal-title":"Neuropharmacology"},{"issue":"3","key":"4125_CR29","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.neubiorev.2010.09.008","volume":"35","author":"MA Smith","year":"2011","unstructured":"Smith MA, Riby LM, Eekelen JAMV, Foster JK. Glucose enhancement of human memory: a comprehensive research review of the glucose memory facilitation effect. Neurosci Biobehav Rev. 2011;35(3):770\u201383. https:\/\/doi.org\/10.1016\/j.neubiorev.2010.09.008.","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"4125_CR30","doi-asserted-by":"publisher","first-page":"987S","DOI":"10.1093\/ajcn\/61.4.987S","volume":"61","author":"P Gold","year":"1995","unstructured":"Gold P. Role of glucose in regulating the brain and cognition. Am J Clin Nutr. 1995;61(4):987S-995S. https:\/\/doi.org\/10.1093\/ajcn\/61.4.987S.","journal-title":"Am J Clin Nutr"},{"key":"4125_CR31","doi-asserted-by":"publisher","unstructured":"Hauck, A., Michael, T., Issler, T. C., Klein, S., Lass-Hennemann, J., & Ferreira De S\u00e1, D. S. Can glucose facilitate fear exposure? Randomized, placebo-controlled trials on the effects of glucose administration on fear extinction processes. Behaviour Research and Therapy. 2024;104553. https:\/\/doi.org\/10.1016\/j.brat.2024.104553.","DOI":"10.1016\/j.brat.2024.104553"},{"issue":"11","key":"4125_CR32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.biopsych.2013.09.022","volume":"75","author":"DE Glenn","year":"2014","unstructured":"Glenn DE, Minor TR, Vervliet B, Craske MG. The effect of glucose on hippocampal-dependent contextual fear conditioning. Biol Psychiatry. 2014;75(11):847\u201354. https:\/\/doi.org\/10.1016\/j.biopsych.2013.09.022.","journal-title":"Biol Psychiatry"},{"key":"4125_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.brat.2015.03.004","volume":"68","author":"AN Niles","year":"2015","unstructured":"Niles AN, Craske MG, Lieberman MD, Hur C. Affect labeling enhances exposure effectiveness for public speaking anxiety. Behav Res Ther. 2015;68:27\u201336. https:\/\/doi.org\/10.1016\/j.brat.2015.03.004.","journal-title":"Behav Res Ther"},{"issue":"3","key":"4125_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0005-7894(00)80026-X","volume":"31","author":"JCI Tsao","year":"2000","unstructured":"Tsao JCI, Craske MG. Timing of treatment and return of fear: effects of massed, uniform-, and expanding-spaced exposure schedules. Behav Ther. 2000;31(3):479\u201397. https:\/\/doi.org\/10.1016\/S0005-7894(00)80026-X.","journal-title":"Behav Ther"},{"key":"4125_CR35","unstructured":"Lehnert, M., Ferreira de S\u00e1, D., Hauck, A., & Michael, T. Glucose as an adjuvant of exposure treatment in participants with public speaking anxiety (PSA). OSF Preregistration.\u00a0https:\/\/osf.io\/v5csq. 2025."},{"issue":"2","key":"4125_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jbtep.2011.10.009","volume":"43","author":"NC Culver","year":"2012","unstructured":"Culver NC, Stoyanova M, Craske MG. Emotional variability and sustained arousal during exposure. J Behav Ther Exp Psychiatry. 2012;43(2):787\u201393. https:\/\/doi.org\/10.1016\/j.jbtep.2011.10.009.","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"1","key":"4125_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/2515245920951503","volume":"4","author":"D Lakens","year":"2021","unstructured":"Lakens D, Caldwell AR. Simulation-based power analysis for factorial analysis of variance designs. Adv Methods Pract Psychol Sci. 2021;4(1):2515245920951503. https:\/\/doi.org\/10.1177\/2515245920951503.","journal-title":"Adv Methods Pract Psychol Sci"},{"issue":"4","key":"4125_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/03637757009375677","volume":"37","author":"JC McCroskey","year":"1970","unstructured":"McCroskey JC. Measures of communication\u2010bound anxiety. Speech Monogr. 1970;37(4):269\u201377. https:\/\/doi.org\/10.1080\/03637757009375677.","journal-title":"Speech Monogr"},{"issue":"3","key":"4125_CR39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/s0005-7894(00)80027-1","volume":"31","author":"SG Hofmann","year":"2000","unstructured":"Hofmann SG, Dibartolo PM. An instrument to assess self-statements during public speaking: scale development and preliminary psychometric properties. Behav Ther. 2000;31(3):499\u2013515. https:\/\/doi.org\/10.1016\/s0005-7894(00)80027-1.","journal-title":"Behav Ther"},{"issue":"2","key":"4125_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1026\/1616-3443.36.2.112","volume":"36","author":"AL Gerlach","year":"2007","unstructured":"Gerlach AL, Heinrichs N, Bandl C, Zimmermann T. SSPS - Ein Fragebogen zur Erfassung der kognitiven Komponente von Redeangst. Z Klin Psychol Psychother. 2007;36(2):112\u201320. https:\/\/doi.org\/10.1026\/1616-3443.36.2.112.","journal-title":"Z Klin Psychol Psychother"},{"key":"4125_CR41","unstructured":"von Consbruch, K., Stangier, U., & Heidenreich, T. SOZAS - Skalen zur Sozialen Angstst\u00f6rung. 2016. https:\/\/www.testzentrale.de\/shop\/skalen-zur-sozialen-angststoerung.html."},{"issue":"4","key":"4125_CR42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1192\/bjp.176.4.379","volume":"176","author":"KM Connor","year":"2000","unstructured":"Connor KM, Davidson JRT, Churchill LE, Sherwood A, Weisler RH, Foa E. Psychometric properties of the social phobia inventory (SPIN): new self-rating scale. Br J Psychiatry. 2000;176(4):379\u201386. https:\/\/doi.org\/10.1192\/bjp.176.4.379.","journal-title":"Br J Psychiatry"},{"key":"4125_CR43","doi-asserted-by":"publisher","unstructured":"MattickRP, Clarke JC. Development and validation of measures of social phobia scrutinyfear and social interaction anxiety. Behav Res Ther. 1998;36(4):455-70. https:\/\/doi.org\/10.1016\/s0005-7967(97)10031-6.","DOI":"10.1016\/s0005-7967(97)10031-6"},{"key":"4125_CR44","doi-asserted-by":"publisher","unstructured":"Stangier, U., Heidenreich, T., Berardi, A., Golbs, U., Hoyer, J. Die Erfassung sozialer Phobie durch die Social Interaction Anxiety Scale (SIAS) und die Social Phobia Scale (SPS). Zeitschrift f\u00fcr Klinische Psychologie und Psychotherapie. 1999;28(1):28\u201336.\u00a0https:\/\/doi.org\/10.1026\/0084-5345.28.1.28.","DOI":"10.1026\/0084-5345.28.1.28"},{"issue":"1","key":"4125_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1891\/1933-3196.2.1.57","volume":"2","author":"D Kim","year":"2008","unstructured":"Kim D, Bae H, Park YC. Validity of the Subjective Units of Disturbance Scale in EMDR. Journal of EMDR Practice and Research. 2008;2(1):57\u201362. https:\/\/doi.org\/10.1891\/1933-3196.2.1.57.","journal-title":"Journal of EMDR Practice and Research"},{"key":"4125_CR46","doi-asserted-by":"publisher","unstructured":"Wolpe, J. Subjective Units of Distress Scale. 1969. https:\/\/doi.org\/10.1037\/t05183-000.","DOI":"10.1037\/t05183-000"},{"issue":"10","key":"4125_CR47","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137. https:\/\/doi.org\/10.1001\/archinte.166.10.1092.","journal-title":"Arch Intern Med"},{"issue":"4","key":"4125_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.genhosppsych.2010.03.006","volume":"32","author":"K Kroenke","year":"2010","unstructured":"Kroenke K, Spitzer RL, Williams JBW, L\u00f6we B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345\u201359. https:\/\/doi.org\/10.1016\/j.genhosppsych.2010.03.006.","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"4125_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.genhosppsych.2005.07.003","volume":"28","author":"A Martin","year":"2006","unstructured":"Martin A, Rief W, Klaiberg A, Braehler E. Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population. Gen Hosp Psychiatry. 2006;28(1):71\u20137. https:\/\/doi.org\/10.1016\/j.genhosppsych.2005.07.003.","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"4125_CR50","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0005-7967(94)00075-u","volume":"33","author":"PF Lovibond","year":"1995","unstructured":"Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335\u201343. https:\/\/doi.org\/10.1016\/0005-7967(94)00075-u.","journal-title":"Behav Res Ther"},{"key":"4125_CR51","unstructured":"Nilges, P., & Essau, C. DASS. Depressions-Angst-Stress-Skalen\u2014Deutschsprachige Kurzfassung. 2021.\u00a0https:\/\/www.psycharchives.org\/en\/item\/5bcda8ff-b672-43e3-a6e8-6cbc598bf37e."},{"issue":"2","key":"4125_CR52","doi-asserted-by":"publisher","DOI":"10.4314\/afrrev.v12i2.13","volume":"12","author":"AO Coker","year":"2018","unstructured":"Coker AO, Coker OO, Sanni D. Psychometric properties of the 21-item depression anxiety stress scale (DASS-21). Afr Res Rev. 2018;12(2):135. https:\/\/doi.org\/10.4314\/afrrev.v12i2.13.","journal-title":"Afr Res Rev"},{"key":"4125_CR53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brat.2014.04.006","volume":"58","author":"MG Craske","year":"2014","unstructured":"Craske MG, Treanor M, Conway CC, Zbozinek T, Vervliet B. Maximizing exposure therapy: An inhibitory learning approach. Behav Res Ther. 2014;58:10\u201323. https:\/\/doi.org\/10.1016\/j.brat.2014.04.006.","journal-title":"Behav Res Ther"},{"key":"4125_CR54","doi-asserted-by":"publisher","unstructured":"Pittig A, Heinig I, Goerigk S, Richter J, Hollandt M, Lueken U, et al. Change of threat expectancy as mechanism of exposure-based psychotherapy for anxiety disorders: evidence from 8,484 exposure exercises of 605 patients. Clin Psychol Sci. 2022. https:\/\/doi.org\/10.1177\/21677026221101379.","DOI":"10.1177\/21677026221101379"},{"issue":"4","key":"4125_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12956","volume":"76","author":"EM Speksnijder","year":"2024","unstructured":"Speksnijder EM, Bisschop PH, Siegelaar SE, Stenvers DJ, Kalsbeek A. Circadian desynchrony and glucose metabolism. J Pineal Res. 2024;76(4):e12956. https:\/\/doi.org\/10.1111\/jpi.12956.","journal-title":"J Pineal Res"},{"key":"4125_CR56","unstructured":"Leiner, D. J. SoSci Survey (Version 3.5.02) [Computer Software].\u00a0https:\/\/www.soscisurvey.de. 2024."},{"issue":"4","key":"4125_CR57","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.3758\/s13428-015-0665-1","volume":"48","author":"J Blechert","year":"2016","unstructured":"Blechert J, Peyk P, Liedlgruber M, Wilhelm FH. ANSLAB: Integrated multichannel peripheral biosignal processing in psychophysiological science. Behav Res Methods. 2016;48(4):1528\u201345. https:\/\/doi.org\/10.3758\/s13428-015-0665-1.","journal-title":"Behav Res Methods"},{"issue":"1","key":"4125_CR58","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev-clinpsy-050212-185542","volume":"9","author":"B Vervliet","year":"2013","unstructured":"Vervliet B, Craske MG, Hermans D. Fear extinction and relapse: state of the art. Annu Rev Clin Psychol. 2013;9(1):215\u201348. https:\/\/doi.org\/10.1146\/annurev-clinpsy-050212-185542.","journal-title":"Annu Rev Clin Psychol"},{"issue":"12","key":"4125_CR59","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1176\/appi.ajp.2011.11040557","volume":"168","author":"BM Graham","year":"2011","unstructured":"Graham BM, Milad MR. The study of fear extinction: implications for anxiety disorders. Am J Psychiatry. 2011;168(12):1255\u201365. https:\/\/doi.org\/10.1176\/appi.ajp.2011.11040557.","journal-title":"Am J Psychiatry"}],"container-title":["BMC Psychology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40359-026-04125-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40359-026-04125-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40359-026-04125-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:26:40Z","timestamp":1781634400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40359-026-04125-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4125"],"URL":"https:\/\/doi.org\/10.1186\/s40359-026-04125-0","relation":{},"ISSN":["2050-7283"],"issn-type":[{"value":"2050-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial was approved by the ethics committee of the faculty for human and business sciences of Saarland University (reference number 20\u201327). Any deviations from the study protocol or preregistration, as well as any adverse events that may arise during the trial, will be explicitly stated in the publication of the trial results. All participants provided written informed consent prior to being included in the trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"268"}}